Here’s a Preview of the Startups Pitching in the Medical Device Track at MedCity INVEST

09 May 2023
medcitynews.com
As we gear up for MedCity INVEST, May 22-24, at the Ritz Carlton in Chicago, we turn our attention to the Pitch Perfect startup contest, which takes center stage at this conference. Startups in the medical device track reflect a diverse selection of companies spanning cardiac monitoring, trauma care, and screening newborns for disease. Click here to register and to view the full agenda. The medical device track will take place on Monday, May 22, from 3:55 pm to 5:10 pm CT Each track of the competition will enable startups to present their companies and then a team of investor judges will ask questions based on the presentation. Judges for the medical device track are: Harry Glorikian, general partner, Scientia Ventures Dr. Oliver Keown, managing director, Intuitive Ventures Dr. Julien Pham, founder and managing partner, 3CC | Third Culture Capital Here’s a preview of the finalists for the medical device track: CEO: Joanna Nathan Prana Thoracic is a medtech business dedicated to developing solutions for early intervention in lung cancer. It seeks to revolutionize the early diagnosis and treatment of lung cancer by making it easier and less invasive to deal with the rapidly growing number of early suspicious lung nodules. CEO: Thorsten Waloschek NeoPrediX develops smart algorithms that predict the progression of certain maternal and newborn disease parameters into the future. CEO: Jonathan Maron VenoVision develops non-invasive cardiac imaging tech and monitoring to reduce ICU admissions and hospitalizations for millions of heart failure and at-risk patients. CEO: Bryan Stewart HDO Health is a medtech company that’s produced a novel, class II, non-sterile, non-invasive, single-use device designed to stop junctional bleeding quickly. The device is designed for combat and trauma environments. It has an intuitive design, requiring little-to-no training by a novice user. The device is durable, and pre-assembled as a single device with a compact design optimized for quick deployment in harsh operating conditions. It allows direct pressure on the wound while remaining in place during patient transport. CEO and Founder: Marc Aafjes Deliberate AI focuses on data-driven multimodal assessments of psychiatric and neurological health. Its products use machine learning and audio-visual signals to generate clinical outcome assessments for depression and anxiety. CEO: Ashley Moy Cast21 is an orthopedics company that’s developed a waterproof alternative to a cast or brace for bone and joint care. It can be applied and removed without heat, water, or specialized equipment.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-
Drugs
-
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.